XOMA Royalty is a biotech royalty aggregator focused on acquiring economic rights to future milestone and royalty payments from pre-commercial therapeutic assets developed by pharmaceutical and biotech companies. The company provides non-dilutive funding to support drug development, leveraging a diverse portfolio of over 120 assets.
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →